These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5438284)

  • 1. Long-term daily outpatient heparin therapy in hyperlipemic and normolipemic atherosclerotic states.
    Woldow A; Goldberg H; Gratz M
    Angiology; 1970 Mar; 21(3):180-7. PubMed ID: 5438284
    [No Abstract]   [Full Text] [Related]  

  • 2. [Control of fat clearance insufficiency in hyperlipemic atherosclerosis].
    Zeller W; Christ F
    Med Klin; 1966 Jan; 61(4):136-9. PubMed ID: 5983158
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse reactions associated with heparin therapy for ischemic heart disease and thrombophlebitis.
    Mishler JM
    Am J Hosp Pharm; 1973 Dec; 30(12):1158-61. PubMed ID: 4763223
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new pharmacological association in therapy of dyslipidemic and arteriosclerotic syndromes].
    Cucinotta D
    Minerva Med; 1972 Feb; 63(15):870-85. PubMed ID: 4259330
    [No Abstract]   [Full Text] [Related]  

  • 5. [General therapy of arteriosclerosis].
    Siedek H
    Wien Klin Wochenschr; 1969 Jun; 81(25):464-6. PubMed ID: 5809151
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 7. Diet and coronary heart disease: a review of the committee of diet and heart disease of the National Heart Foundation of Australia.
    Med J Aust; 1979 Sep; 2(6):294-307. PubMed ID: 392275
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of heparin electrophoresis in treating coronary arteriosclerosis].
    Shustval' NF
    Vopr Kurortol Fizioter Lech Fiz Kult; 1973; 38(1):23-8. PubMed ID: 4775663
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin resistance in relation to hyperlipidemia and hypercoagulability in atherosclerotic diabetics and non-diabetics.
    Higazi AM; el-Ebrashy N; Aly AM; el-Din AS
    J Egypt Med Assoc; 1972; 55(8):577-94. PubMed ID: 4658037
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of heparin and fibrinolysin in patients with coronary arteriosclerosis].
    Aleĭnikova LI
    Vrach Delo; 1966 Mar; 3():53-6. PubMed ID: 4230197
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sodium iodoheparinate in the treatment of atherosclerosis and dyslipemia. Apropos of 40 cases].
    Desruelles J; Decalf A; Delcourt P; Waucampt JJ
    Lille Med; 1965; 10(6):666-70. PubMed ID: 5834773
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of heparin upon atherogenesis in the Watanabe heritable hyperlipidemic rabbit.
    Workman JR; Schmidt SP; Donovan DL; Clarke R
    Ann Vasc Surg; 1990 Jul; 4(4):344-9; discussion 349-50. PubMed ID: 2364050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the place of heparin-compound in the physiology and pathology of the vascular wall].
    Franke W; John W
    Ther Ggw; 1966 Jan; 105(1):40-54. PubMed ID: 5914086
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heparinemia and atheroslerosis. Pentosan sulfuropolyester analysis in atherosclerotic dyslipemias].
    Romero RL; Maljar L; Cabuli R; Basso G; Cacciatore J
    Prensa Med Argent; 1967 Jul; 54(20):925-8. PubMed ID: 5615155
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hyperdyslipidemia in chronic atherosclerotic peripheral obliterating arteriopathies of the lower limbs].
    Bagliani A; Argenteri A; La Rosa A
    Clin Ter; 1982 Dec; 103(6):647-61. PubMed ID: 7160147
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hyperlipidemia in patients with ischemic heart disease].
    Haviar V; Kusá O; Riecanský I; Luknárová O
    Vnitr Lek; 1972 Jun; 18(6):586-91. PubMed ID: 5044447
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
    Castello S
    Clin Ter; 1971 Aug; 58(4):323-34. PubMed ID: 4258171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radiometric determination of capillary permeability and tissue circulation in patients with coronary atherosclerosis treated with heparin].
    Aleĭnikova LI; Dubovyĭ ED; Sokolov VN; Kudlaĭ VR
    Klin Med (Mosk); 1972 Oct; 50(10):42-5. PubMed ID: 4656248
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effects of Allium sativum, Allium cepa and Commiphora mukul on experimental hyperlipidemia and atherosclerosis--a comparative evaluation.
    Lata S; Saxena KK; Bhasin V; Saxena RS; Kumar A; Srivastava VK
    J Postgrad Med; 1991 Jul; 37(3):132-5. PubMed ID: 1784023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperlipemia: clinico-therapeutic experience with a heparinoid].
    De Martino G; D'Aniello L; De Simone E; Belli MG; Buonfantino M
    Clin Ter; 1978 Sep; 86(6):583-95. PubMed ID: 83925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.